The research interests of the Division of Infectious Disease cover the following areas: HIV/AIDS; transplantation infectious diseases; experimental pharmacology; fungal infections, pathogenesis of Epstein-Barr virus, streptococcal and other bacterial infections; vaccine development; social medicine; tuberculosis; tropical medicine; and clinical epidemiology.
The Clinical Microbiology Laboratory offers a full range of procedures for isolation and identification of bacterial, mycobacterial, fungal, parasitic and viral infections; antibiotic susceptibility testing; and serology tests for infectious agents. Other locations include the Channing Laboratory, the Harvard School of Public Health, the Department of Global Health and Equity at Harvard Medical School, and affiliated laboratory space at the Mass General Brigham Research Facility on Landsdowne Street in Cambridge.
The Division is actively involved in a variety of clinical research activities related to novel therapeutics. In particular, we have on-going studies related to the treatment of resistant bacterial pathogens, fungae, and HIV. We are active participants in the AIDS Clinical Trials Group (ACTG) and the HIV Vaccine Trials Network (HVTN).
Click here to be directed to the HIV Vaccine Trials Unit.
For more information on current research interests of the Division of Infectious Disease, click here.
